In-vitro Mutagenesis
Experimental RNAi
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 7, 2026

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
Published on: May 23, 2016
Jost Seibler1, Andre Kleinridders, Birgit Küter-Luks
1Artemis Pharmaceuticals GmbH, Neurather Ring 1, Cologne, Germany. j.seibler@artemispharma.de
Researchers developed a novel system for temporal control of short hairpin RNA (shRNA) expression in mice, enabling precise gene silencing. This tool allows for reversible gene knockdown, advancing the study of gene function and disease mechanisms.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: